Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Shares Outstanding (Weighted Average) (2020 - 2025)

Privia Health (PRVA) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $122.2 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 2.32% year-over-year to $122.2 million; the TTM value through Dec 2025 reached $122.2 million, up 2.32%, while the annual FY2025 figure was $122.2 million, 2.32% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $122.2 million in Q4 2025 per PRVA's latest filing, roughly flat from $121.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $122.2 million in Q4 2025 and bottomed at $96.0 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $113.3 million, with a median of $116.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 0.06% in 2021, then increased 12.58% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $103.0 million in 2021, then increased by 7.52% to $110.7 million in 2022, then rose by 5.45% to $116.7 million in 2023, then grew by 2.29% to $119.4 million in 2024, then rose by 2.32% to $122.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $122.2 million in Q4 2025, $121.8 million in Q3 2025, and $122.1 million in Q2 2025.